JACC and the U.S. Food and Drug Administration (FDA) are teaming up to give cardiovascular clinicians a voice in shaping national health care and research priorities. Provide your feedback in a brief survey to identify critical questions surrounding FDA-regulated products – drugs, biologics, devices, food and tobacco – that influence your practice. Help shape the evidence landscape for cardiovascular care by providing your feedback by April 14! Act now.